Brain uptake of thiamine-coated nanoparticles

被引:200
作者
Lockman, PR
Oyewumi, MO
Koziara, JM
Roder, KE
Mumper, RJ
Allen, DD
机构
[1] Texas Tech Univ, HSC, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA
[2] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
关键词
microemulsions; blood-brain barrier; emulsifying wax; targeting; biodistribution;
D O I
10.1016/j.jconrel.2003.08.006
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Recently, a novel nanoparticle (NP) comprised of emulsifying wax and Brij 78 was shown to have significant brain uptake using the in-situ rat brain perfusion technique. To further these studies and to specifically target brain, we have incorporated thiamine as a surface ligand on the nanoparticles. Solid nanoparticles were prepared from oil-in-water microemulsion precursors. Nanoparticles were radiolabeled and a thiamine ligand (thiamine linked to distearoylphosphatidylethanolamine via a polyethylene glycol spacer) was coated on the surface of the nanoparticles. Initial experiments focused on assessing uptake of [H-3]nanoparticles with and without thiamine surface ligands. Biodistribution nanoparticle studies were also carried out in BALB/c mice. The results showed: (1) the effectiveness of using microemulsions as precursors to engineer nanoparticles, (2) kinetic modeling for brain uptake of nanoparticles with and without the thiamine surface ligands, and (3) initial data suggesting mechanisms for nanoparticle brain entry. Comparison of NP brain uptake demonstrated that the thiamine-coated nanoparticle associated with the blood-brain barrier (BBB) thiamine transporter and had an increased K-in between 45 and 120 s (thiamine coated NP 9.8 +/- 1.1 x 10(-3) ml/s/g versus uncoated NPs; 7.0 +/- 0.3 x 10(-3) ml/s/g). It was concluded that the thiamine ligand facilitated binding and/or association with blood-brain barrier thiamine transporters, which may be a viable mechanism for nanoparticle mediated brain drug delivery. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 25 条
  • [11] In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles
    Lockman, PR
    Koziara, J
    Roder, KE
    Paulson, J
    Abbruscato, TJ
    Mumper, RJ
    Allen, DD
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (05) : 705 - 713
  • [12] Nanoparticle technology for drug delivery across the blood-brain barrier
    Lockman, PR
    Mumper, RJ
    Khan, MA
    Allen, DD
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (01) : 1 - 13
  • [13] MOSQUIEIRA VCF, 2001, PHARM RES, V18, P4111
  • [14] Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters
    Oyewumi, MO
    Liu, SQ
    Moscow, JA
    Mumper, RJ
    [J]. BIOCONJUGATE CHEMISTRY, 2003, 14 (02) : 404 - 411
  • [15] Gadolinium-loaded nanoparticles engineered from microemulsion templates
    Oyewumi, MO
    Mumper, RJ
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (03) : 317 - 328
  • [16] OYEWUMI MO, 2003, P ANN C CONTR REL SO
  • [17] Drug and gene delivery to the brain: The vascular route
    Pardridge, WM
    [J]. NEURON, 2002, 36 (04) : 555 - 558
  • [18] Brain drug targeting and gene technologies
    Pardridge, WM
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 87 (02) : 97 - 103
  • [19] Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of iv dalargin injections
    Schroder, U
    Sabel, BA
    [J]. BRAIN RESEARCH, 1996, 710 (1-2) : 121 - 124
  • [20] Smith Q R, 1996, Pharm Biotechnol, V8, P285